Th17/Treg细胞在健脾方防治克罗恩大鼠中的作用机制(5)
[5]Globig AM，Hennecke N，Martin B，et al.Comprehensive intestinal T helper cell profiling reveals specific accumulation of IFN-γ+IL-17+coproducing CD4+ T cells in active inflammatory bowel disease[J].Inflamm Bowel Dis，2014，20(12)：2321-2329.
[6]Maizels RM，Pearce EJ，Artis D，et al.Regulation of pathogenesis and immunity in helminth infections[J].J Exp Med，2009，206(10)：2059-2066.
[7]Harrington LE，Hatton RD，Mangan PR，et al.Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages[J].Nat Immunol，2005，6(11)：1123-1132.
, 百拇医药
[8]Hori S，Nomura T，Sakaguchi S.Pillars Article： Control of Regulatory T Cell Development by the Transcription Factor Foxp3[J].J Immunol，2017，198(3)：981-985.
[9]Ueno A，Jijon H，Chan R，et al.Increased prevalence of circulating novel IL-17 secreting Foxp3 expressing CD4+ T cells and defective suppressive function of circulating Foxp3+ regulatory cells support plasticity between Th17 and regulatory T cells in inflammatory bowel disease patients[J].Inflamm Bowel Dis，2013，19(12)：2522-2534.
, 百拇医药
[10]Zhou L，Chong MM，Littman DR.Plasticity of CD4+ T cell lineage differentiation[J].Immunity，2009，30(5)：646-655.
[11]Zhou L，Lopes JE，Chong MM，et al.TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function[J].Nature，2008，453(7192)：236-240.
[12]Mucida D，Park Y，Kim G，et al.Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid[J].Science，2007，317(5835)：256-260.
, 百拇医药
[13]吳婷，陈广洁. miRNA调控Th细胞分化的研究进展[J].现代免疫学，2015，35(4)：334-337.
[14]Wu LY，Ma XP，Shi Y，et al.Alterations in microRNA expression profiles in inflamed and non-inflamed ascending colon mucosae of patients with active Crohn′s disease[J].J Gastroenterol Hepatol，2017，150(4)：S572.
[15]Fitzpatrick LR.Inhibition of IL-17 as a pharmacological approach for IBD[J].Int Rev Immunol，2013，32(5-6)：544-555.
[16]Ng SC，Lam YT，Tsoi KK，et al.Systematic review： the efficacy of herbal therapy in inflammatory bowel disease[J].Aliment Pharmacol Ther，2013，38(8)：854-863.
, 百拇医药
[17]Rahimi R，Nikfar S，Abdollahi M.Induction of clinical response and remission of inflammatory bowel disease by use of herbal medicines：a meta-analysis[J].World J Gastroenterol，2013，19(34)：5738-5749.
[18]Yu Z，Liu HJ，Dun HH，et al.Effect of Pulsatilla Decoction on the expression of proinflammatory cytokines in inflammatory bowel disease[J].Chinese Journal of Applied Physiology，2011，27(4)：416-419., http://www.100md.com(吴璐一 翁志军 季光)
[6]Maizels RM，Pearce EJ，Artis D，et al.Regulation of pathogenesis and immunity in helminth infections[J].J Exp Med，2009，206(10)：2059-2066.
[7]Harrington LE，Hatton RD，Mangan PR，et al.Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages[J].Nat Immunol，2005，6(11)：1123-1132.
, 百拇医药
[8]Hori S，Nomura T，Sakaguchi S.Pillars Article： Control of Regulatory T Cell Development by the Transcription Factor Foxp3[J].J Immunol，2017，198(3)：981-985.
[9]Ueno A，Jijon H，Chan R，et al.Increased prevalence of circulating novel IL-17 secreting Foxp3 expressing CD4+ T cells and defective suppressive function of circulating Foxp3+ regulatory cells support plasticity between Th17 and regulatory T cells in inflammatory bowel disease patients[J].Inflamm Bowel Dis，2013，19(12)：2522-2534.
, 百拇医药
[10]Zhou L，Chong MM，Littman DR.Plasticity of CD4+ T cell lineage differentiation[J].Immunity，2009，30(5)：646-655.
[11]Zhou L，Lopes JE，Chong MM，et al.TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function[J].Nature，2008，453(7192)：236-240.
[12]Mucida D，Park Y，Kim G，et al.Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid[J].Science，2007，317(5835)：256-260.
, 百拇医药
[13]吳婷，陈广洁. miRNA调控Th细胞分化的研究进展[J].现代免疫学，2015，35(4)：334-337.
[14]Wu LY，Ma XP，Shi Y，et al.Alterations in microRNA expression profiles in inflamed and non-inflamed ascending colon mucosae of patients with active Crohn′s disease[J].J Gastroenterol Hepatol，2017，150(4)：S572.
[15]Fitzpatrick LR.Inhibition of IL-17 as a pharmacological approach for IBD[J].Int Rev Immunol，2013，32(5-6)：544-555.
[16]Ng SC，Lam YT，Tsoi KK，et al.Systematic review： the efficacy of herbal therapy in inflammatory bowel disease[J].Aliment Pharmacol Ther，2013，38(8)：854-863.
, 百拇医药
[17]Rahimi R，Nikfar S，Abdollahi M.Induction of clinical response and remission of inflammatory bowel disease by use of herbal medicines：a meta-analysis[J].World J Gastroenterol，2013，19(34)：5738-5749.
[18]Yu Z，Liu HJ，Dun HH，et al.Effect of Pulsatilla Decoction on the expression of proinflammatory cytokines in inflammatory bowel disease[J].Chinese Journal of Applied Physiology，2011，27(4)：416-419., http://www.100md.com(吴璐一 翁志军 季光)